-
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
[ad_1] Atlanta, GA – (NewMediaWire) – February 8, 2021 – GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology…
Read More » -
News
8 research projects totaling $900K funded to focus on congenital heart defects
[ad_1] (NewMediaWire) – February 08, 2021 – DALLAS – For healthcare professionals and families to better understand and treat the number…
Read More » -
Featured
NanoViricides’s Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies
Shelton, CT – February 8, 2021 — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a global leader in the development of…
Read More » -
News
Emotional Wellness Company DSOL Announces New CEO as Founder Steps Up To Chairwoman
[ad_1] Chicago, IL – (NewMediaWire) – February 04, 2021 – Drug Free Solution, Inc. dba Get Your Feelz On (OTC:…
Read More »